Literature DB >> 30083068

Thrombosis in children: Which test to whom, when and how much necessary?

Tiraje Celkan1, Gürcan Dikme1.   

Abstract

Pediatric thrombosis is multifactorial, and usually risk factors either congenital or acquired are present. After 2000, systematic reviews and meta-analysis on pediatric venous thromboembolic disease and inherited thrombophilia revealed elevated thrombotic risks in these children. In this review, we discuss thrombosis and new literature in various pediatric patient groups and the usefulness of thrombophilia testing.

Entities:  

Keywords:  Childhood trombophilia; diagnosis of thrombosis; treatment of thrombosis

Year:  2018        PMID： 30083068      PMCID： PMC6070222          DOI： 10.5152/TurkPediatriArs.2018.2586

Source DB:  PubMed          Journal:  Turk Pediatri Ars


  48 in total

1.  Recommendations on testing for thrombophilia in venous thromboembolic disease: a French consensus guideline.

Authors:  G Pernod; C Biron-Andreani; P-E Morange; F Boehlen; J Constans; F Couturaud; L Drouet; B Jude; T Lecompte; G Le Gal; N Trillot; D Wahl
Journal:  J Mal Vasc       Date:  2009-05

2.  Recurrence rate after a first venous thrombosis in patients with familial thrombophilia.

Authors:  Carla Y Vossen; Isobel D Walker; Peter Svensson; Juan C Souto; Inge Scharrer; F Eric Preston; Gualtiero Palareti; Ingrid Pabinger; Felix J M van der Meer; Mike Makris; Jordi Fontcuberta; Jacqueline Conard; Frits R Rosendaal
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-06-23       Impact factor: 8.311

3.  Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH).

Authors:  A Tosetto; A Iorio; M Marcucci; T Baglin; M Cushman; S Eichinger; G Palareti; D Poli; R C Tait; J Douketis
Journal:  J Thromb Haemost       Date:  2012-06       Impact factor: 5.824

4.  The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.

Authors:  Paolo Prandoni; Franco Noventa; Angelo Ghirarduzzi; Vittorio Pengo; Enrico Bernardi; Raffaele Pesavento; Matteo Iotti; Daniela Tormene; Paolo Simioni; Antonio Pagnan
Journal:  Haematologica       Date:  2007-02       Impact factor: 9.941

Review 5.  Inherited thrombophilia: a double-edged sword.

Authors:  Saskia Middeldorp
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 6.  Pediatric thrombophilia.

Authors:  Janet Y K Yang; Anthony K C Chan
Journal:  Pediatr Clin North Am       Date:  2013-12       Impact factor: 3.278

7.  Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study.

Authors:  Trevor Baglin; Roger Luddington; Karen Brown; Caroline Baglin
Journal:  Lancet       Date:  2003-08-16       Impact factor: 79.321

8.  A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.

Authors:  Lesley G Mitchell; Maureen Andrew; Kim Hanna; Thomas Abshire; Jacqueline Halton; Ron Anderson; Irene Cherrick; Sunil Desai; Donald Mahoney; Patricia McCuster; John Wu; Gary Dahl; Peter Chait; Gabrielle de Veber; Kyong-Jin Lee; David Mikulis; Jeffrey Ginsberg; Cliford Way
Journal:  Cancer       Date:  2003-01-15       Impact factor: 6.860

Review 9.  The psychological impact of testing for thrombophilia: a systematic review.

Authors:  D M Cohn; F Vansenne; A A Kaptein; C A J M De Borgie; S Middeldorp
Journal:  J Thromb Haemost       Date:  2008-07-01       Impact factor: 5.824

10.  Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE.

Authors:  M Andrew; M David; M Adams; K Ali; R Anderson; D Barnard; M Bernstein; L Brisson; B Cairney; D DeSai
Journal:  Blood       Date:  1994-03-01       Impact factor: 22.113
View more
  7 in total

1.  Protein S deficiency in an adolescent female with disseminated tuberculosis presenting as deep vein thrombosis: confounder or correlation?

Authors:  Najeeb Ahmad; Swathi Chacham; Avinish Singh; Lourembam Radha Ppyari; Manish Kumar
Journal:  Sudan J Paediatr       Date:  2022

2.  The danger awaiting premature babies: Portal vein thrombosis.

Authors:  Salih Çağrı Çakır; Hilal Özkan; Bayram Ali Dorum; Nilgün Köksal; Pınar Kudretoğlu; Birol Baytan; Melike Sezgin; Adalet Meral Güneş
Journal:  Turk Pediatri Ars       Date:  2020-09-23

3.  Changes in Hematological, Clinical and Laboratory Parameters for Children with COVID-19: Single-Center Experience.

Authors:  Mahasen Saleh; Amani Alkofide; Anfal Alshammari; Khawar Siddiqui; Tarek Owaidah
Journal:  J Blood Med       Date:  2021-09-04

Review 4.  Current Antithrombotic Therapy Strategies in Children with a Focus on Off-Label Direct Oral Anticoagulants-A Narrative Review.

Authors:  Stefana Maria Moisa; Laura Mihaela Trandafir; Crischentian Brinza; Ingrith Crenguta Miron; Elena Tarca; Lacramioara Ionela Butnariu; Alexandru Burlacu
Journal:  Children (Basel)       Date:  2022-07-21

5.  Pulmonary Embolism in Childhood: A Multicenter Experience from Turkey

Authors:  Melih Hangül; Mehmet Köse; Sevgi Pekcan; Ümran Çalışkan; Hüseyin Tokgöz; Ayşe Tana Aslan; Tuğba Şişmanlar Eyüboğlu; Tuğba Ramaslı Gürsoy; Nihan Kırçıl; Ali Ersoy; Tahir Tok; Aslı İmran Yılmaz
Journal:  Balkan Med J       Date:  2022-09-09       Impact factor: 3.570

6.  An Unusual Case Study of Idiopathic Bilateral Deep Vein Thrombosis and Osteonecrosis of the Left Distal Tibia in an 11-year-old Girl.

Authors:  Sarah M Choi; Darius R Rad; Eleanor C Carpenter
Journal:  J Orthop Case Rep       Date:  2022-03

7.  Thrombophilia testing: A British Society for Haematology guideline.

Authors:  Deepa J Arachchillage; Lucy Mackillop; Arvind Chandratheva; Jayashree Motawani; Peter MacCallum; Mike Laffan
Journal:  Br J Haematol       Date:  2022-05-29       Impact factor: 8.615
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.